Intensity-controlled Raster Scanning Carbon Ion Radiation Therapy With a Heavy-ion Gantry: Clinical Experience at Heidelberg Ion Beam Therapy Center

PURPOSE: Carbon ions have biophysical advantages over photons, including a finite range, increased relative biological effectiveness, and lowered oxygen dependence. Maximum treatment flexibility is attainable with rotational beam delivery. We report our clinical experience using the carbon-ion gantry at the Heidelberg Ion Beam Therapy Center with intensity-controlled raster scanning capability, focusing on treatment toxicity. METHODS AND MATERIALS: A total of 1622 patients treated using the carbon-ion gantry between 2012 and 2026 were evaluated. Data were analyzed using descriptive statistics. Toxicity analysis was conducted using Common Terminology Criteria of Adverse Events v5.0. RESULTS: The median age preradiation therapy was 59 years (range, 18-91). Most patients had locally advanced tumors (21.8% T4; 11.2% T3) without regional lymph node metastases (45.4% N0). The most common treatment indications were sacrococcygeal tumors (n = 331; 20.4%), followed by tumors of the paranasal sinuses (n = 166; 10.2%) and the spine (n = 121; 7.5%). A total of 486 patients (30.0%) received carbon-ion reirradiation, the most frequent carbon-ion gantry treatment indication viewed across all patients. The most common particle therapy beam-angle number was 2 (range, 1-7). The use of more than 2 beam angles was particularly frequent in tumors of the skull base (45.8%) and the thoracic region (40.0%). High-grade (III and IV) acute and late toxicity rates were 2.4% and 4.2% in primary treatment. Mean numbers of acute and late grade I and II toxicity events per patient were 2.2 (95% confidence interval, 2.0-2.4) and 2.0 (95% confidence interval, 1.7-2.4), respectively. CONCLUSIONS: Carbon-ion radiation therapy using a heavy-ion gantry resulted in favorable toxicity rates in specific indications. Further interdisciplinary research demonstrating the clinical benefit of carbon-ion radiation therapy is required. This study provides more evidence supporting particle therapy facilities and may serve as a foundation for prospective clinical trials.

Authors

Institutions

Publication Details

Journal
International Journal of Radiation Oncology*Biology*Physics
Published
2026-11-17
DOI
https://doi.org/10.1016/j.ijrobp.2026.09.003
Primary Topic
Radiation Therapy and Dosimetry
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Intensity-controlled Raster Scanning Carbon Ion Radiation Therapy With a Heavy-ion Gantry: Clinical Experience at Heidelberg Ion Beam Therapy Center

Semi Harrabi, Stella Winter, Henrik Franke, Thomas Held et al.
1 links
International Journal of Radiation Oncology*Biology*Physics
Radiation Therapy and Dosimetry
article

Intensity-controlled Raster Scanning Carbon Ion Radiation Therapy With a Heavy-ion Gantry: Clinical Experience at Heidelberg Ion Beam Therapy Center

Semi Harrabi, Stella Winter, Henrik Franke, Thomas Held, Malte Ellerbrock, Klaus K Herfarth, Sebastian Adeberg, Cihangir Çakır, Andrea Mairani, Katharina Dvornikovich, Thomas Haberer, Marcus Winter, Jürgen Debus, Mia Sittinger, Ziqi Cathy Jiang, Leonhard Dörsam, Till Manzey
article en

Abstract

PURPOSE: Carbon ions have biophysical advantages over photons, including a finite range, increased relative biological effectiveness, and lowered oxygen dependence. Maximum treatment flexibility is attainable with rotational beam delivery. We report our clinical experience using the carbon-ion gantry at the Heidelberg Ion Beam Therapy Center with intensity-controlled raster scanning capability, focusing on treatment toxicity. METHODS AND MATERIALS: A total of 1622 patients treated using the carbon-ion gantry between 2012 and 2026 were evaluated. Data were analyzed using descriptive statistics. Toxicity analysis was conducted using Common Terminology Criteria of Adverse Events v5.0. RESULTS: The median age preradiation therapy was 59 years (range, 18-91). Most patients had locally advanced tumors (21.8% T4; 11.2% T3) without regional lymph node metastases (45.4% N0). The most common treatment indications were sacrococcygeal tumors (n = 331; 20.4%), followed by tumors of the paranasal sinuses (n = 166; 10.2%) and the spine (n = 121; 7.5%). A total of 486 patients (30.0%) received carbon-ion reirradiation, the most frequent carbon-ion gantry treatment indication viewed across all patients. The most common particle therapy beam-angle number was 2 (range, 1-7). The use of more than 2 beam angles was particularly frequent in tumors of the skull base (45.8%) and the thoracic region (40.0%). High-grade (III and IV) acute and late toxicity rates were 2.4% and 4.2% in primary treatment. Mean numbers of acute and late grade I and II toxicity events per patient were 2.2 (95% confidence interval, 2.0-2.4) and 2.0 (95% confidence interval, 1.7-2.4), respectively. CONCLUSIONS: Carbon-ion radiation therapy using a heavy-ion gantry resulted in favorable toxicity rates in specific indications. Further interdisciplinary research demonstrating the clinical benefit of carbon-ion radiation therapy is required. This study provides more evidence supporting particle therapy facilities and may serve as a foundation for prospective clinical trials.

International Journal of Radiation Oncology*Biology*PhysicsVol. 126(5)
German Cancer Research Center (DE), Heidelberg University (DE), University Hospital Heidelberg (DE), Heidelberger Institut für Radioonkologie (DE), National Center for Tumor Diseases (DE)
Good health and well-being
Radiation Therapy and Dosimetry
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon